SLS

SELLAS Life Sciences Group, Inc. - Common Stock (SLS)

About SELLAS Life Sciences Group, Inc. - Common Stock (SLS)

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Details

Daily high

$11.94

Daily low

$11.13

Price at open

$11.59

52 Week High

$15.88

52 Week Low

$1.39

Market cap

2.3B

Dividend yield

Volume

123,341

Avg. volume

7.6M

P/E ratio

-54.15

SELLAS Life Sciences Group, Inc. - Common Stock News